377
Views
7
CrossRef citations to date
0
Altmetric
Studies in humans

Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension

, , , , , , , , & show all
Pages 60-70 | Received 28 Dec 2020, Accepted 26 Mar 2021, Published online: 25 Apr 2021

References

  • Acharjee S, Zhou JR, Elajami TK, Welty FK. 2015. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism. 64(2):236–243.
  • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 120(16):1640–1645.
  • Bauer UE, Briss PA, Goodman RA, Bowman BA. 2014. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 384(9937):45–52.
  • Colacurci N, Chiàntera A, Fornaro F, de Novellis V, Manzella D, Arciello A, Chiàntera V, Improta L, Paolisso G. 2005. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause. 12(3):299–307.
  • Collaborators GRF. 2018. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 392(10159):1923–1994.
  • Czerwiecki L. 2009. Contemporary view of plant antioxidants role in prevention of civilization diseases. Rocz Panstw Zakl Hig. 60(3):201–206.
  • Du SS, Jiang YS, Chen Y, Li Z, Zhang YF, Sun CH, Feng RN. 2015. Development and applicability of an Internet-Based Diet and Lifestyle Questionnaire for college students in China: a cross-sectional study. Medicine. 94(49):e2130.
  • Ekman A, Litton JE. 2007. New times, new needs; e-epidemiology. Eur J Epidemiol. 22(5):285–292.
  • Feng RN, Du SS, Chen Y, Li Z, Zhang YF, Sun CH, Jiang YS. 2016. An internet-based food frequency questionnaire for a large Chinese population. Asia Pac J Clin Nutr. 25(4):841–848.
  • Grosso G, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, Galvano F, Giovannucci EL. 2017. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr Rev. 75(6):405–419.
  • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109(3):433–438.
  • Guo P, Zhu H, Pan H, Feng R, Chen Y, Wang Y, Wang X, Li Y, Yang L, Zhou B, et al. 2019. Dose–response relationships between dairy intake and chronic metabolic diseases in a Chinese population. J Diabetes. 11(11):846–856.
  • Hazim S, Curtis PJ, Schär MY, Ostertag LM, Kay CD, Minihane AM, Cassidy A. 2016. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr. 103(3):694–702.
  • Hossain P, Kawar B, El Nahas M. 2007. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 356(3):213–215.
  • Jackson RL, Greiwe JS, Schwen RJ. 2011. Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist. Nutr Rev. 69(8):432–448.
  • Kim MH, Kang KS. 2012. Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. Prev Med. 54(Suppl):S57–S63.
  • Kim J, Lee H, Lee O, Lee KH, Lee YB, Young KD, Jeong YH, Choue R. 2013. Isoflavone supplementation influenced levels of triglyceride and luteunizing hormone in Korean postmenopausal women. Arch Pharm Res. 36(3):306–313.
  • Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 116(22):2553–2562.
  • Lelong H, Blacher J, Baudry J, Adriouch S, Galan P, Fezeu L, Hercberg S, Kesse-Guyot E. 2017. Individual and combined effects of dietary factors on risk of incident hypertension: prospective analysis from the NutriNet-Santé Cohort. Hypertension. 70(4):712–720.
  • Leng L, Jiang ZQ, Ji GY. 2011. Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats. Zhonghua Yu Fang Yi Xue Za Zhi. 45(4):335–339.
  • Liu H, Zhong H, Leng L, Jiang Z. 2017a. Effects of soy isoflavone on hepatic steatosis in high fat-induced rats. J Clin Biochem Nutr. 61(2):85–90.
  • Liu H, Zhong H, Yin Y, Jiang Z. 2017b. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats. Biomed Pharmacother. 91:964–969.
  • Lu LW, Chen NW, Nayeem F, Nagamani M, Anderson KE. 2020. Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial. Eur J Nutr. 59(6):2369–2381.
  • Medina-Remon A, Kirwan R, Lamuela-Raventos RM, Estruch R. 2018. Dietary patterns and the risk of obesity, type 2 diabetes mellitus, cardiovascular diseases, asthma, and neurodegenerative diseases. Crit Rev Food Sci Nutr. 58(2):262–296.
  • Moradi M, Daneshzad E, Azadbakht L. 2020. The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 60(20):3414–3428.
  • Pandey KB, Rizvi SI. 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2(5):270–278.
  • Paszkiewicz M, Budzyńska A, Różalska B, Sadowska B. 2012. The immunomodulatory role of plant polyphenols. Postepy Hig Med Dosw (Online). 66:637–646.
  • Patten GS, Abeywardena MY, Bennett LE. 2016. Inhibition of angiotensin converting enzyme, angiotensin II receptor blocking, and blood pressure lowering bioactivity across plant families. Crit Rev Food Sci Nutr. 56(2):181–214.
  • Peluso MR, Winters TA, Shanahan MF, Banz WJ. 2000. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J Nutr. 130(9):2333–2342.
  • Pérez-Jiménez J, Hubert J, Hooper L, Cassidy A, Manach C, Williamson G, Scalbert A. 2010. Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr. 92(4):801–809.
  • Ramdath DD, Padhi EM, Sarfaraz S, Renwick S, Duncan AM. 2017. Beyond the cholesterol-lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease. Nutrients. 9(4):324.
  • Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. 2005. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem. 16(6):321–330.
  • Salomone F, Ivancovsky-Wajcman D, Fliss-Isakov N, Webb M, Grosso G, Godos J, Galvano F, Shibolet O, Kariv R, Zelber-Sagi S. 2020. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. JHEP Rep. 2(2):100069.
  • Simón J, Casado-Andrés M, Goikoetxea-Usandizaga N, Serrano-Maciá M, Martínez-Chantar ML. 2020. Nutraceutical properties of polyphenols against liver diseases. Nutrients. 12(11):3517.
  • Uesugi T, Fukui Y, Yamori Y. 2002. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr. 21(2):97–102.
  • Uhlig CE, Seitz B, Eter N, Promesberger J, Busse H. 2014. Efficiencies of Internet-based digital and paper-based scientific surveys and the estimated costs and time for different-sized cohorts. PLoS One. 9(10):e108441.
  • Vedavanam K, Srijayanta S, O’Reilly J, Raman A, Wiseman H. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res. 13(7):601–608.
  • Wilunda C, Sawada N, Goto A, Yamaji T, Iwasaki M, Tsugane S, Noda M. 2020. Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study. Eur J Nutr. 59(5):2075–2087.
  • Yamakoshi J, Piskula MK, Izumi T, Tobe K, Saito M, Kataoka S, Obata A, Kikuchi M. 2000. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr. 130(8):1887–1893.
  • Yang YX. 2004. China food composition tables. Beijing: Peking University Medical Press.
  • Yang YX. 2018. China food composition tables. Beijing: Peking University Medical Press.
  • Yang YX. 2019. China food composition tables. Beijing: Peking University Medical Press.
  • Yang YX, Wang GY, Pan XC. 2009. China food composition tables. Beijing: Peking University Medical Press.
  • Zhan S, Ho SC. 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 81(2):397–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.